Brand Name
Geodon
Generic Name
Ziprasidone
View Brand Information FDA approval date: March 02, 2012
Classification: Atypical Antipsychotic
Form: Injection, Capsule
What is Geodon (Ziprasidone)?
GEODON is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. GEODON intramuscular is indicated for acute agitation in schizophrenic patients. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions.
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
Summary: This multi-centre study will evaluate the safety and related factors study of atypical antipsychotics long-term treatment in Chinese Patients with Schizophrenia. The atypical antipsychotics include quetiapine, olanzapine, risperidone, aripiprazole, ziprasidone, paliperidone , amisulpride , perospirone and clozapine. This is an open, cohort, multi-center observational clinical study. The main purpo...